SIR-Estrogens act on various monoamine systems in the brain, affect synaptogenesis and have neuroprotective properties. Previously, estrogen receptor (ER) polymorphisms have been related to personality traits. We found that in women ERa haplotypes created by the PvuII (c.454-397T4C) and the XbaI (c.454-351A4G) polymorphisms increased the likelihood of having an anxiety but not of having a depressive disorder; no relation between mood or anxiety disorders and ERa haplotypes was observed in men.
This study is based on data from the Rotterdam Study, a population-based cohort of persons over 55 years. A random selection of 2468 participants of a Caucasian origin filled in the Hospital Anxiety and Depression Scale (HADS) during the second examination and was genotyped. Anxiety was defined as a score of 11 or more on the HADS-anxiety subscale, which traditionally denotes probable anxiety disorder. 1 We found a probable anxiety disorder in 148 (6.0%) persons. Additionally, we defined a more homogenous group with anxiety and no comorbid depression. This group (n ¼ 84) was restricted to those with a HADS-depression score of less than 11. Depressive disorders were assessed with the Center for Epidemiological Studies Depression scale (CES-D) in 4098 persons participating in the third examination (1997) (1998) (1999) . Screen-positive subjects (cut-off score was 16) had a psychiatric interview with the present state examination to classify depression according to DSM-IV criteria. In total, 321 (7.8%) screened positive for depressive symptoms and of these, 132 had a DSM-IV depressive disorder.
We studied two single nucleotide polymorphisms (SNP) identified in the ERa gene, the c.454-397T4C (also known as PvuII) and the c.454-351A4G (also known as XbaI), to define haplotypes as described previously.
2 All SNPs were genotyped with Taqman Assays-by-Design SNP Genotyping Service and ABI PRISM s 7900HT Sequence Detection System (both: Applied Biosystems). The association of the ERa haplotype with depressive symptoms, and depressive disorders, and anxiety was assessed separately in men and women using logistic regression and testing an allele-dose model. Only the results of the ERa PvuIIXbaI haplotype 1 (frequency 52.8%) are reported as the haplotype alleles are closely related. Genotype distribution was in Hardy-Weinberg equilibrium.
The ERa haplotype 1 was associated with the likelihood of having anxiety in women, but not in (Table 1) or DSM-IV depressive disorder (P ¼ 0.73 for women and P ¼ 0.72 for men). Studies of the putative association of ERa haplotypes and variations in behavior have been sparse. ERa polymorphisms have been associated with parent's report of anxiety at the age of 13-14 years. 3 Other studies concentrated on personality traits rather than specific mood states. 4, 5 Furthermore, opposite findings were reported in men and women. A gender difference like in our study may be explained by the cessation of gonadal function in postmenopausal women, who have lower estrogen levels than men. 6 Interestingly, our observations are supported by very detailed studies of behavior in ERa knockout mice. 7 Female ERa knockout mice were more aggressive, whereas the respective male mice showed hardly any offensive attacks as compared to wild-type mice. At the same time, anxiety and fear levels were increased in female mice but not in male knockout mice. Further support for a role of the ERa in anxiety comes from studies of the receptor distribution in the human brain. ERa mRNA is expressed at relatively higher levels in the amygdala and the hypothalamus, both involved in emotional regulation. 8 Our results suggest that ERa haplotypes may increase the risk of having an anxiety, but not a depressive, disorder. This is remarkable as anxiety is very frequently accompanied by symptoms of depression. Our observation could be a false-positive finding. However, the population-based design, the large sample, and the allele-dose effect support a true association. Furthermore, ERa haplotypes increased the likelihood of anxiety without significant comorbid depression. This is in line with studies showing that the perimenopausal period is characterized by mild affective symptoms, whereas the incidence of mood disorders does not increase. 9 Moreover, the core features of the perimenopausal period and the perimenstrual syndrome are irritability, nervousness and tension rather than a depressed effect.
Evidence of association between bipolar disorder and Citron on chromosome 12q24 SIR -Bipolar disorder (BP) has a predominantly genetic etiology that has been supported by twin, adoption, and family studies. Several genome-wide linkage analyses conducted for BP have identified a variety of susceptibility loci, including chromosome 4p16, 12q24, 18p11.2, 18q22, 21q21, 22q11-13, and Xq26. 1 Many of these loci overlap with those found in schizophrenia (SZ), suggesting common genetic susceptibility factors for both BP and SZ.
In a Scottish family, a hereditary balanced (1;11)(q42.1;q14.3) chromosomal translocation is segregated with major mental illnesses including BP, recurrent major depression, and SZ. 2 The translocation leads to an interference in the open reading frame of the Disrupted-in-Schizophrenia-1 (DISC1) gene that could produce a C-terminal truncated DISC1 protein. In a previous study, we conducted a yeast two-hybrid screening in order to identify possible protein interactors involved with cellular signaling of DISC1. 3 Among more than 30 interacting proteins, we selected Citron for further analyses because the gene encoding Citron is located on chromosome 12q24, a frequently reported locus linked with BP. [4] [5] [6] Citron is a synaptic and cytoskeletal protein that can potentially modulate glutamatergic neurotransmission, 7 a hypothesized mechanism for BP. In dividing cells, Citron is required for cytokinesis and is also implicated for neurogenesis. 8 Considering its chromosomal location, interaction with DISC1, and possible roles in the synapse, we hypothesize that Citron may be one of several important candidate genes for BP. Therefore, we conducted a family-based association study of the Citron gene and BP.
